ArticleFrontiers in oncology2022

Development and validation of a novel immunotype for prediction of overall survival in patients with clear cell renal cell carcinoma.

Deshui Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.